ACTRN12617000078358终止2 期
Perampanel for the control of glioma associated seizures – efficacy and safety: a pilot phase II randomised controlled trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 11
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Pre-operative phase (ie inclusion for 7T MRI)
- •1. 18 – 80 years
- •2. Radiological diagnosis of a supratentorial WHO grade II-III glioma
- •3. Planned surgical resection or biopsy of lesion
- •4. 3T MRI performed as clinical standard of care
- •5. Able to give informed consent
- •6. Experienced a pre-operative seizure attributed to glioma
- •Post-operative phase (ie inclusion for treatment intervention)
- •1. 18-80 years
- •2. Diagnosis of WHO grade II-III glioma
- •3. Less than 3 weeks from date of glioma resection or biopsy
- •4. Experienced a pre-operative seizure attributed to glioma
排除标准
- •1. Previous non-tumour related neurosurgical procedures (excluding biopsy of glioma)
- •2. Pre-operative chemotherapy or radiotherapy
- •3. Receiving >1000mg daily of levetiracetam or multiple concurrent anti-epileptic drugs at time of randomization
- •4. Contraindication to 7T MRI
- •5. Significant risk factors for non-tumour associated epilepsy
- •- Previously diagnosed epilepsy (excluding benign childhood epilepsies)
- •- Additional epileptogenic intra-cranial pathology (including intra-cranial complications from glioma resection)
- •6. History of major psychiatric morbidity (such as psychiatric illness requiring hospitalisation or history of psychosis, major depression or suicidality) within the last 2 years
- •7. Pregnant or breast-feeding
- •8. Excessive alcohol or recreational drug use
研究者
相似试验
终止
2 期
Perampanel for the prevention of glioma associated seizures – efficacy and safetyTumour associated epilepsyNeurological - EpilepsyCancer - BrainGliomaACTRN12617000073303Melbourne Health40
撤回
不适用
Efficacy and Safety of Perampanel in Combination in Glioma-refractory EpilepsyRefractory EpilepsyNCT03636958Assistance Publique Hopitaux De Marseille
尚未招募
1 期
Clinical trial for recurrent malignant gliomas using boron neutron capture therapy and bevacizumabJPRN-UMIN000013419Dept. of Neurosurgery, Osaka Medical College50
进行中（未招募）
1 期
Study to evaluate the potentiation effect of radiotherapy by AGuIX nanoparticles for the treatment of persistent glioblastomaPersistent Glioblastoma Multiforme, grade IVMedDRA version: 20.0Level: PTClassification code 10018337Term: Glioblastoma multiformeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-003774-32-ITDIPARTIMENTO BIOMEDICINA E PREVENZIONE UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA30
进行中（未招募）
1 期
Investigating the use of levetiracetam to prevent seizures after brain surgery.Seizures in patients with suspected cerebral gliomaMedDRA version: 20.0Level: PTClassification code 10018338Term: GliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10061030Term: Brain tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-001312-30-GBCommon Services Agency804